Health Care: Drugs

Amicus Therapeutics Inc (FOLD: NASDAQ)

$6.3 -0.55 | -8.03%
10/06/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 6.85
52 Week High 18.83
52 Week Low 5.13
Avg. Daily Vol. (Mil) 3.29
Beta (3 year) 2.35
Share Related Items
Mkt Cap (Mil) 812.53
Shares Out (Mil) 118.62
Float (Mil) 68.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 21.40
Current Ratio 21.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 2.77K
Price/Book 2.47
Price/Cash Flow -9.20
Per Share Data
Earnings -0.99
Sales 0.00
Book Value 2.77
Cash Flow -0.74
Business Summary
Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines for orphan diseases.
General Information
1 Cedar Brook Drive
Cranbury, NJ 08512
Industry : Drugs
Sector: Health Care
Employees: 97
CEO: John F. Crowley
Short Interest
Current Month (Mil) 14.86
Previous Month (Mil) 14.14
Short Interest Ratio (Days) 7.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -22.20
Return on Investments -27.30
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with FOLD

Latest FOLD Headlines from TheStreet

More Financial News for FOLD

Press Releases for FOLD

See All Press Releases

Partner Headlines for FOLD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter